Olympus Corporation - ADR logo

Olympus Corporation - ADR (OLY)

Market Closed
12 Jun, 20:00
XFRA XFRA
8. 75
-0.2
-2.2346%
12.01B Market Cap
51.17 P/E Ratio
72% Div Yield
0 Volume
0 Eps
8.95
Previous Close
Add Transaction
Day Range
8.7 8.75
Year Range
6.8 11.3
Want to track OLY and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

OLY closed Friday lower at €8.75, a decrease of -2.2346% from Thursday's close, completing a monthly decrease of -5.4054% or -€0.5. Over the past 12 months, OLY stock lost -15.0485%.
OLY pays dividends to its shareholders, with the most recent payment made on Jul 09, 2018. The next estimated payment will be in 9 Jul 2018 on Jul 09, 2018 for a total of €0.06342.
The last earnings report, released on May 08, 2026, missed the consensus estimates by -0.029%. On average, the company has surpassed earnings expectations by 0.0589%, based on the last three reports.
Olympus Corporation - ADR has completed 1 stock splits, with the recent split occurring on Apr 09, 2019.
The company's stock is traded on 2 different exchanges and in various currencies, with the primary listing on OTC PINK (USD).

OLY Chart

People also search for

SAP SE Depositary Receipt
3.06
-1.2903%
Nvidia Corporation Unsponsored Depositary Receipt
6.75
-2.8777%
ABE
ABE
8.85
+1.7241%
Apple Inc. Depositary Receipt (APC0)
6.4
-0.7752%
Intel Corporation Depositary Receipt
20.6
+11.3514%

Olympus Corporation - ADR (OLY) FAQ

What is the stock price today?

The current price is €8.75.

On which exchange is it traded?

Olympus Corporation - ADR is listed on XFRA.

What is its stock symbol?

The ticker symbol is OLY.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 72%.

What is its market cap?

As of today, the market cap is 12.01B.

Has Olympus Corporation - ADR ever had a stock split?

Olympus Corporation - ADR had 1 splits and the recent split was on Apr 09, 2019.

Olympus Corporation - ADR Profile

Electronic Equipment, Instruments & Components Industry
Information Technology Sector
Frank Drewalowski CEO
XFRA Exchange
US68163W2089 ISIN
JP Country
29,297 Employees
31 Mar 2025 Last Dividend
9 Apr 2019 Last Split
- IPO Date

Overview

Olympus Corporation, originally known as Olympus Optical Co., Ltd., is a global leader in the manufacturing and sale of precision machinery and instruments. The company has a rich history that dates back to its inception in 1919 and has its headquarters situated in Tokyo, Japan. Over the years, Olympus Corporation has undergone significant transformations, including a name change in October 2003, to better reflect its diversified product range and global presence. Olympus operates through four main business segments: Endoscopic Solutions, Therapeutic Solutions, Scientific Solutions, and Others. Each of these segments is geared towards providing innovative solutions in their respective fields, contributing to Olympus's reputation as a pioneer in medical and scientific equipment.

Products and Services

  • Endoscopic Solutions Business

    This segment delivers a comprehensive array of gastrointestinal and surgical endoscopy systems alongside surgical microscopes. Olympus also offers endoscope reprocessors and maintenance services, ensuring the durability and reliability of its endoscopic products. The focus here is on enhancing the efficiency of medical procedures and improving patient outcomes through state-of-the-art imaging and minimally invasive techniques.

  • Therapeutic Solutions Business

    Olympus's offering in this domain includes a variety of products for urology, gynecology, respiratory care, as well as ear, nose, and throat (ENT) treatments. The segment is particularly noted for its GI endo-therapy devices, energy devices, and surgical single-use devices, which are designed to facilitate complex therapeutic procedures with precision and care.

  • Scientific Solutions Business

    This segment caters to the needs of the scientific community, providing biological and industrial microscopes, industrial videoscopes, and non-destructive testing equipment. Additionally, Olympus supplies X-ray fluorescence (XRF) analyzers, instruments key in material analysis across various industries. The focus here is on delivering precision, enhancing research capabilities, and contributing to the advancement of science and industry.

  • Others

    Under this segment, Olympus develops and supplies biomedical materials such as synthetic bone fillers and orthopedic equipment. These products are a testament to Olympus’s commitment to extending its technological expertise beyond traditional boundaries and meeting the diverse needs of its global clientele.

Contact Information

Address: 2951 Ishikawa-machi
Phone: 81 42 642 2111